AU2247095A - Cellular immune response-specific antigens and uses therefor - Google Patents

Cellular immune response-specific antigens and uses therefor

Info

Publication number
AU2247095A
AU2247095A AU22470/95A AU2247095A AU2247095A AU 2247095 A AU2247095 A AU 2247095A AU 22470/95 A AU22470/95 A AU 22470/95A AU 2247095 A AU2247095 A AU 2247095A AU 2247095 A AU2247095 A AU 2247095A
Authority
AU
Australia
Prior art keywords
immune response
cellular immune
specific antigens
uses therefor
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22470/95A
Inventor
Lei Ding
Raghupathi Rao Koganty
B. Michael Longenecker
Mark A. Reddish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncothyreon Canada Inc
Original Assignee
Biomira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Inc filed Critical Biomira Inc
Publication of AU2247095A publication Critical patent/AU2247095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU22470/95A 1994-04-12 1995-04-12 Cellular immune response-specific antigens and uses therefor Abandoned AU2247095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22960694A 1994-04-12 1994-04-12
US229606 1994-04-12
PCT/US1995/004540 WO1995027505A1 (en) 1994-04-12 1995-04-12 Cellular immune response-specific antigens and uses therefor

Publications (1)

Publication Number Publication Date
AU2247095A true AU2247095A (en) 1995-10-30

Family

ID=22861949

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22470/95A Abandoned AU2247095A (en) 1994-04-12 1995-04-12 Cellular immune response-specific antigens and uses therefor

Country Status (2)

Country Link
AU (1) AU2247095A (en)
WO (1) WO1995027505A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2116497A (en) * 1996-01-31 1997-08-22 Population Council, The Multivalent chimeric peptides as microbicides
WO1997035008A1 (en) * 1996-03-21 1997-09-25 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods and compositions of chimeric polypeptides for tumor antigen vaccines
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2441809C (en) 2001-03-27 2014-07-22 Biomira, Inc. Liposomal vaccines comprising dilipopeptides for modulating t1 and t2 immune responses
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
WO2003015796A1 (en) * 2001-08-14 2003-02-27 Biomira, Inc. Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
WO2003094850A2 (en) 2002-05-09 2003-11-20 Biomira, Inc. Lipid a and other carbohydrate ligand analogs
TWI395591B (en) 2004-04-01 2013-05-11 Oncothyreon Inc Mucinous glycoprotein (muc-1) vaccine
JP5364371B2 (en) 2005-06-28 2013-12-11 オンコセリオン インコーポレイテッド Methods of treating patients with mucin glycoprotein (MUC-1) vaccines
JP2014518841A (en) 2011-02-24 2014-08-07 オンコシレオン インク． MUC1-based glycolipopeptide vaccine with adjuvant
DE102013105144A1 (en) * 2013-05-17 2014-11-20 Arno Thaller Combination pharmaceutical preparation with an anti-idiotypic antibody fragment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501719A (en) * 1988-11-10 1992-03-26 インペリアル・キヤンサー・リサーチ・テクノロジー・リミテツド polypeptide
EP0661996A4 (en) * 1991-11-19 1997-05-21 Anergen Inc Mhc subunit conjugates useful in ameliorating deleterious immune responses.
WO1994004557A1 (en) * 1992-08-11 1994-03-03 President And Fellows Of Harvard College Immunomodulatory peptides

Also Published As

Publication number Publication date
WO1995027505A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
AU4518196A (en) Adjuvant-incorporated cellular antigens: conjugation and methods
AU2395895A (en) Melanoma antigens
PL330111A1 (en) Concentyratyed antibody preparation
ZA959336B (en) Antibodies
AU2749895A (en) Structural cellular component
AU4239896A (en) Dihydropyrimidines and uses thereof
AU4278696A (en) Yeast telomerase components and methods using them
AU1021997A (en) Cd100 antigen and uses therefor
AU2391195A (en) Lymphocyte activation antigens and antibodies thereto
AU2705395A (en) Fas associated proteins
AU7422496A (en) NM03 antibody materials and methods
EP0805161A4 (en) (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
AU2247095A (en) Cellular immune response-specific antigens and uses therefor
AU6820796A (en) Antigenic preparations
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
GB9423372D0 (en) Proteins and their uses
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
AU3308495A (en) New Toxoplasma gondii antigens
IL118324A0 (en) Immunoregulatory polypeptide and its uses
AU3776495A (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas
AU2881495A (en) Cyclohexanocephalosporins and their preparation procedure
AU2765697A (en) Metastasis-associated antigen and antibodies thereto
AU645641B2 (en) Babesial protease antigen
AUPM541594A0 (en) Ligands and antibodies directed thereto